Back

Gut Microbiota and Associated Metabolites Play a Key Role in the Pathogenesis of the Obesity Phenotype of Heart Failure With Preserved Ejection Fraction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Basic and Translational Late-Breaking Science Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Rabea Asleh

Hadassah-Hebrew University Medical Centre, Jerusalem (Israel)

7 More presentations in this session

Presentation thumbnail
Distinct cellular and molecular trajectories leading to subclinical diastolic dysfunction and the progression to HFpEF
Doctor E. Lara-Pezzi (Madrid, ES)
Slides Video
Presentation thumbnail
Different cardiovascular outcomes of vascular ageing proteomic phenogroups in normotensive and hypertensive individuals: results from the UK Biobank.
Professor T. Guzik (Edinburgh, GB)
Slides Video
Presentation thumbnail
Polygenic traits and cardiac remodelling contribute to a markedly increased risk of atrial fibrillation in former elite endurance athletes
Professor A. La Gerche (Melbourne, AU)
Slides Video
Presentation thumbnail
Echocardiographic screening for cardiac amyloidosis using artificial intelligence: A multi-site study for algorithm training and external validation.
Professor P. Pellikka (Rochester, US)
Slides Video
Presentation thumbnail
An isocaloric high fat diet enriched with saturated compared to polyunsaturated fat has a more detrimental effect on clinical cardiometabolic risk factors in healthy humans
Mr N. Srnic (Oxford, GB)
Slides Video

Access the full session

Session thumbnail
Basic and Translational Late-Breaking Science
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources